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Abstract
Background: Although the cerebellum is considered to be predominantly involved in fine motor control,
emerging evidence documents its participation in language, impulsive behavior and higher cognitive functions.
While the specific connections of the cerebellar deep nuclei (CDN) that are responsible for these functions are still
being worked out, their deficiency has been termed “cerebellar cognitive affective syndrome” - a syndrome that
bears a striking similarity to many of the symptoms of Alzheimer’s disease (AD). Using ectopic cell cycle events and
DNA damage markers as indexes of cellular distress, we have explored the neuropathological involvement of the
CDN in human AD.
Results: We examined the human cerebellar dentate nucleus in 22 AD cases and 19 controls for the presence of
neuronal cell cycle events and DNA damage using immunohistochemistry and fluorescence in situ hybridization.
Both techniques revealed several instances of highly significant correlations. By contrast, neither amyloid plaque
nor neurofibrillary tangle pathology was detected in this region, consistent with previous reports of human
cerebellar pathology. Five cases of early stage AD were examined and while cell cycle and DNA damage markers
were well advanced in the hippocampus of all five, few indicators of either cell cycle events (1 case) or a DNA
damage response (1 case) were found in CDN. This implies that CDN neurons are most likely affected later in the
course of AD. Clinical-pathological correlations revealed that cases with moderate to high levels of cell cycle
activity in their CDN are highly likely to show deficits in unorthodox cerebellar functions including speech,
language and motor planning.
Conclusion: Our results reveal that the CDN neurons are under cellular stress in AD and suggest that some of the
non-motor symptoms found in patients with AD may be partly cerebellar in origin.
Background
The cerebellum has traditionally been considered to be a
brain structure that is primarily involved in the regula-
tion of motor coordination, balance and the motor
aspects of speech. This view is changing, however, as
recent studies have made it clear that the role of the
cerebellum extends to higher cognitive functions includ-
ing language and executive functioning. The cerebellar
hemispheres are substantially enlarged in the human
brain and the interaction of their output neurons in the
dentate nucleus with higher cortical areas is particularly
noteworthy. For a full discussion and list of references
the reader is referred to the recent review by Strick
et al. [1]. Emphasis on this expanded view of cerebellar
function can also be found in the variety of linguistic
and behavioral disorders that are found to occur follow-
ing acquired cerebellar lesions [2]. The common fea-
tures of these functional deficiencies have been termed
“cerebellar cognitive affective syndrome” [3] - a set of
symptoms that bears a striking similarity to many of the
known symptoms of AD.
Neuronal loss in the cerebellum is part of the normal
aging process in human. According to the early study of
Hall et al. (1975), the loss of cerebellar Purkinje cells
occurs at a rate of 2.5% per decade; the functional con-
sequences of this cerebellar atrophy on neurological
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functions are unknown [4]. However, the cerebellum is
not uniformly affected during the aging process. For exam-
ple, there is currently no evidence of age-related neuronal
loss in the dentate or other cerebellar nuclei [5]. The
impact of aging on cerebellum and its multimodal interac-
tions with the rest of the brain led us to question whether
the neuropathological changes in this brain region might
contribute to the neurological and behavioral symptoms of
Alzheimer’s disease. The degeneration of Purkinje and
granule cells has been reported in both familial and spora-
dic AD [6,7]. Studies have shown diffuse amyloid plaques
in the cerebellar cortex of AD patients. The majority of
these deposits occur in the molecular layer, and while they
may extend into the Purkinje cell layer they rarely occur in
the granule cell layer [8,9]. Ubiquitin-immunoreactive dys-
trophic neurites, increased microglial density and evidence
of astrocytosis are also found in the AD cerebellum
[6,10,11]. In the later stages of AD, a reduction of cerebel-
lar glucose metabolism is observed [12]; and classic cere-
bellar functions such as balance and gait are also affected
[13,14]. Despite these observations, the cerebellum is still
widely regarded as being spared by Alzheimer’s disease -
often serving as a control tissue or a reference region in
imaging studies.
The cerebellum, through its role in the response to
pain and emotion, has been linked to behavioral changes
such as impulsive behavior. In patients with AD, sec-
ondary behavioral manifestations range from hyperactiv-
ity to agitation, and impulsive behaviors are common
[15]. Motor impulsivity has also been shown in trans-
genic mice carrying the human APP gene with the
Swedish mutation for familial AD (APPsw mice) [16],
providing strong evidence of a direct link between
mutant APP and this single behavioral AD phenotype
both in human and mouse. Impulsive behavior has been
traced to abnormalities in the cerebellar deep nuclei, the
output nuclei of the cerebellum [17]. While the deep
cerebellar nuclei in AD are largely devoid of amyloid
deposits and tau inclusions, quantitative MR phase-cor-
rected imaging has revealed increased iron deposition
[18]. Iron is often cited for its role in the production of
oxidative damage during the progression of AD, raising
the significance of this observation. In addition, the loss
of cerebellar dentate neurons has been documented in
AD with myoclonus [19]. Taken together, these observa-
tions suggest that the deep cerebellar nuclei are plausi-
ble targets of AD pathology.
Our studies of the biological causes of neuronal death
in AD have been guided by our observation of cell cycle
reentry in cellular populations that degenerate in human
disease [20-22]. Many other laboratories have reported
similar findings (references in Herrup and Yang,
2007 [23]). The value of this perspective has been
demonstrated in our analyses of mouse models of AD.
While neurodegeneration is rarely seen in mouse, in the
R1.40 AD mouse model there is a good correspondence
between the sites of unscheduled cell cycle events
(CCEs) and the areas subject to neurodegeneration in
human AD [24-26].
In addition to ectopic cell cycling, AD is also linked to
DNA damage. Accumulation of DNA damage in neurons
is associated with aging [27] and is exacerbated in neuro-
degenerative disorders including AD [28,29]. The correla-
tion of both CCE and DNA damage with the appearance
of AD suggests that there may be a link between these
two processes. This prompted us to ask whether patholo-
gical changes can be found in CDN neurons from AD
using early markers of cellular stress. In pursuit of this
question, we examined the cerebellar dentate nucleus in
46 AD and control specimens at various disease stages.
Our outcome measures included the appearance of DNA
damage responses and ectopic cell cycle events revealed
by immunohistochemistry and fluorescent in situ hybridi-
zation (FISH) analysis of DNA replication. We find that
the cerebellar dentate nuclei are indeed involved in the
pathogenesis of AD, but that their involvement does not
begin until the disease is established. Clinical-pathological
correlations reveal that cases with moderate to high levels
of cell cycle activity in their CDN are highly likely to
show deficits in unorthodox cerebellar functions includ-
ing speech, language and motor planning. We propose
that the symptoms of AD are reasonably ascribed, at least
in part, to a loss of cerebellar function.
Results
Cell cycle events are elevated in AD cerebellar dentate
nuclei
Human cerebellar tissue sections containing both cortex
and dentate nucleus from 41 individuals were examined
(22 AD; 19 controls). Male to female ratio in both
groups were about 1 to 1. Age and post mortem interval
(PMI) of AD and control cases were comparable: AD
(age = 79 ± 11 years; PMI = 18 ± 17 hours); control
(age = 72 ± 19 years; PMI = 19 ± 20 hours). Figure 1
illustrates the type of results we see when we perform
immunohistochemistry for cell cycle markers including
cyclin A, PCNA and Cdk4. The number of cyclin A
positive cerebellar dentate neurons was generally low,
but some AD brains contained significant numbers of
such neurons (Figure 1B). To provide additional depth
to this analysis, we established a rating scale for staining
intensity and performed a quantitative comparison
based on the average of these scores. As a group, the
cerebellar nuclei of AD subjects contained significantly
more cyclin A positive neurons than controls (p =
0.0004, Table 1). Importantly, cyclin A expression corre-
lated well with Alzheimer’s disease diagnosis and/or
with Braak stage (p = 0.0002, Table 2).
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Cdk4, a G1 cell cycle kinase also revealed a staining
pattern that was well correlated with disease. In our
material, we found that immunoreactive Cdk4 could be
found in two different sub-cellular distributions. In non-
demented controls, nuclear Cdk4 could be seen in the
neurons of the cerebellar dentate nucleus in 3 of 15
cases. Only 1 out of 20 AD cases showed this pattern in
dentate neurons. In the AD cases, however, there were
significant numbers of neurons in which the nucleolus
was strongly stained for Cdk4 while the remaining
nucleoplasm was relatively immunonegative. An exam-
ple of such a cell is shown in Figure 1D. Cell counts
revealed that there were significantly more dentate
nucleus neurons with nucleolar Cdk4 in AD brains than
in controls (p = 0.0005, Table 1). There was also a
robust correlation between nucleolar Cdk4 and AD
diagnosis (p = 0.0009, Table 2).
Figure 1 Cell cycle markers are present in cerebellar dentate
nuclear neurons in material from cases with human AD.
Immunostaining for cyclin A, Cdk4 and PCNA are indicated by black
arrows in controls (A, C, E) and AD cases (B, D, F). (A-B) Cyclin A
(arrows) was found in the nucleus of neurons in the cerebellar
dentate nucleus in some AD cases but not controls. The brown
material is lipofuscin. (C-D) Strong nucleolar staining of Cdk4,
against a background of clear nucleoplasm (arrows), was more
prevalent in AD material (D) than in control (C). (E-F) PCNA
immunostained neurons were found in the cerebellar dentate
nucleus, but controls (E) and AD cases (F) showed no significant
difference.
Table 1 Staining scores for cell cycle and DNA damage
markers
Case Number Diagnoses Immunocytochemical score
CycA PCNA Cdk4 53BP1 pATM
1 AD 0 1 1 2 -
2 AD 1 - 2 1 -
3 AD 3 2 2 5 4
4 AD 0 0 5 0 0
5 AD 1 0 2 0 5
6 AD 1 0 4 0 3
7 AD 0 1 5 0 3
8 AD 1 1 2 5 4
9 AD 1 1 1 0 -
10 AD 2 0 0 4 5
11 AD 0 1 2 4 5
12 AD 1 0 2 5 5
13 AD 3 3 5 0 5
14 AD 0 1 1 3 5
15 AD 0 1 0 5 -
16 AD 1 1 - 0 -
17 AD 0 0 - 2 -
18 AD 3 3 5 2 0
19 AD 1 0 5 4 5
20 AD 4 3 1 1 1
21 AD 2 1 4 1 3
22 AD 0 0 4 0 5
23 Con 0 0 0 0 0
24 Con 0 0 0 1 0
25 Con 0 2 0 2 0
26 Con 0 2 0 0 0
27 Con 0 0 0 0 0
28 Con 0 1 3 0 4
29 Con 0 0 2 0 -
30 Con 0 0 0 1 0
31 Con 0 0 0 0 0
32 Con 0 0 0 0 0
33 Con 0 0 0 0 0
34 Con 0 0 2 0 0
35 Con - 2 0 0 0
36 Con 0 3 - 0 0
37 Con 0 2 - 0 0
38 Con 0 2 - 0 0
39 Con 0 2 - 0 0
40 Con 1 1 1 0 0
41 Con 0 1 3 2 0
P value t-test (2-tailed) CycA PCNA Cdk4 53BP1 P-ATM
0.0004 1.0 0.0005 0.001 0.000001
Each sample was scored based on % of CDN neurons stained and the staining
intensity. 0 = no staining; 1 = very few cells stained or weakly stained; 2 =
moderate staining, 5-10% of the CDN neurons; 3 = 10-25% moderately to
strongly stained; 4 = more than 25% strongly stained; 5 = more than 50%
strongly stained. The p-values were calculated with Student’s t-test, 2-tailed.
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Despite these indications of a reactivation of cell cycle
processes in cerebellar dentate nuclei of the AD brain,
we found that there was no significant difference (p =
1.0, Table 1) between AD and controls in the number of
dentate nuclei immunoreactive for PCNA (proliferating
cell nuclear antigen), a component of the DNA replica-
tion complex that is elevated during S-phase. Neither
was there any correlation between the presence of
PCNA staining and AD diagnosis (p = 0.34, Table 2).
This discrepancy was unexpected, but led us to consider
the fact that PCNA is involved in DNA damage repair
[30] as well as in DNA replication.
DNA damage responses are detected in AD cerebellum
Cellular stresses, including DNA damage, have been
linked to cell cycle deregulation in neurons [31,32]. Our
observation of cell cycle reactivation in neurons of the
cerebellar dentate nucleus in AD prompted us to inves-
tigate the status of the DNA damage sensor and G2/M
check point protein, 53BP1. 53BP1 is a p53 binding pro-
tein, which has been shown to be a reliable marker for
DNA damage [33]. We found that there were many
more 53BP1 stained cerebellar dentate nucleus neurons
in AD brains (Figure 2B) than in controls (Figure 2A)
and this difference was statistically significant (p =
0.001, Table 1). Further, the level of 53BP1 expression
correlated well with AD diagnosis (p = 0.01, Table 2).
53BP1 is also a substrate of ATM (ataxia-telangiectasia
mutated), a PI3 kinase that is activated by auto-phos-
phorylation (on serine 1981) soon after DNA double
strand breaks appear. To determine whether the 53BP1
response was reflective of a broader ATM-dependent
response to DNA damage, we examined ATM auto-
phosphorylation with a phospho-ser1981 specific anti-
body (Figure 2C, D). We found significantly increased
numbers of phospho-ser1981 ATM (P-ATM)-positive
cerebellar dentate neurons in the AD cases compared to
the control material (p = 0.0001) supporting the data we
obtained from the 53BP1 immunostaining (Table 1 and
Figure 2A, B). There was a good correlation between
the two DNA damage makers (r = 0.6, p = 0.003).
Three cases (2 AD, 1 control) had extensive P-ATM
staining but were not immunoreactive to 53BP1 anti-
body. The biological implication of this discordance
between P-ATM and 53BP1 in these cases is not clear.







Chi-square with Yates correction
2 p(< 0.05)
Cyclin A + 14 1 0.0002 11.88 0.0006
- 8 17
PCNA + 13 8 0.34 0.59 0.44
- 8 10
Cdk4 + 18 5 0.0009 9.83 0.002
- 2 10
53BP1 + 14 4 0.01 5.88 0.015
- 8 15
P-ATM + 12 1 0.0001 16.1 0.0001
- 2 15
Cases marked “+” represent positively stained cases with scores between 1 and 5; cases marked “-” represent those with scores of 0
Figure 2 Evidence of DNA damage can be detected in AD
cerebellar deep nuclear neurons and surrounding non-
neuronal cells. (A-B) 53BP1 staining is virtually absent in control
material (A) but robust in neurons of the AD cases (B); (C-D)
Phosphorylated S1981 ATM (P-ATM) is much less prominent in
control (C) than in AD (D) material; (E-F) Phosphorylated T68 of the
cell cycle checkpoint kinase, Chk2 (P-Chk2) is less apparent in
control (E) than in AD (F) material, but the cells that are stained in
the AD deep nucleus are most likely astrocytes, not neurons. The
insert in F validates this interpretation. Its shows double staining of
P-Chk2 (red) and GFAP (green), an astrocyte marker.
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Overall, P-ATM seemed to correlate with AD diagnosis
better than 53BP1 (Table 1 and 2). Of note, staining
with phospho-specific antibodies against the phosphory-
lated isoform of the cell cycle checkpoint kinase, Chk2
(P-Chk2), was also positively correlated with disease
state (Figure 2E, F), but the staining was not in the cere-
bellar dentate neurons themselves. Instead, activated P-
Chk2 was observed in mostly small, non-neuronal cells.
These cells were most likely activated astrocytes as they
could be double labeled with GFAP and P-Chk2 (Figure
2F, inset).
Onset of deep nuclear abnormalities in the Alzheimer’s
disease process
The finding of a strong disease correlation with several
of the stress markers used in this study raises the ques-
tion of whether the cerebellar dentate nuclear involve-
ment is present from the beginning of the disease or is,
instead, a later symptom of disease progression. To
address this question, we stained five samples from indi-
viduals with very early signs of AD (CDR 0.5) (Table 3).
Of the five, only two were significantly reactive for
either cell cycle or DNA damage makers in cerebellar
deep nuclei. Case HCB07 had significant numbers of
53BP1-positive CDN neurons as well as several PCNA
positive cells, likely indications of DNA damage. We
detected no cyclin A staining in this case (nor was there
significant P-ATM staining). The reverse situation was
found in case HCB11, which had significant numbers of
cell cycle events but little evidence of a DNA damage
response. This was in contrast to material from the hip-
pocampus of the same cases. Here, as reported
previously [22], robust cell cycle reentry was found in all
5. Markers of DNA damage were also elevated in this
area. While the sample size is small, the strong sugges-
tion is that cerebellar involvement begins after the
disease has become manifest in neocortical and hippo-
campal structures.
Cell cycle deregulation and the DNA damage response
The fact that cell cycle and DNA damage events are not
co-localized during early stage AD suggests that these
two events are temporally sequential or mutually exclu-
sive. This is somewhat unexpected as DNA damage has
been shown to cause cell cycle reentry in cultured neu-
rons [31,32]. It might also be presumed that forced cell
cycle re-entry in a post-mitotic neuron would induce
DNA damage. We re-examined our cerebellar data and
found that, analyzed case by case, there was no signifi-
cant correlation between the cell cycle and DNA
damage markers we tested in this study. Within each
case, a high cell cycle index (cyclin A) did not correlate
with a high score in the DNA damage response (P-
ATM) and vise versa (Table 1 and 3). To determine
whether there is a link between DNA damage and cell
cycle deregulations in individual cerebellar dentate neu-
ron, we performed double immuno-labeling of the
human AD sections. We found no overlap between the
two processes in either cerebellum or hippocampus. An
example of our findings from the CDN can be found in
Figure 3. The cell cycle marker cyclin A (Figure 3 red
arrow) and the DNA damage marker 53BP1 (Figure 3
black arrow) and P-ATM (Figure 3 blue arrow) were
consistently found in different CDN neurons. Coupled
with our observations from cases of early stage AD
(Table 3), the findings suggest that DNA damage and
cell cycle reentry are mutually exclusive events in the
CDN and hippocampal pyramidal neurons.
FISH (Fluorescent In Situ Hybridization) reveals
hyperploidy in deep nuclear neurons
Elevated levels of cell cycle proteins are not normally
found in post-mitotic nerve cells. When they appear,
they are usually taken as evidence for the re-initiation of
a cell cycle process. The discovery of two indicators of
DNA damage in the same neuronal population, how-
ever, cautions that the proteins might be expressed in
the service of DNA repair rather than DNA replication.
To relate our findings with cell cycle and DNA damage
proteins to the presence of true cell cycling, we exam-
ined the number of chromosome copies present in cere-
bellar dentate neurons of AD and control cases using
fluorescent in situ hybridizaiton (FISH). A total of 16
samples (8 AD, 5 controls, 3 disease controls) proved
usable for this analysis. The remaining cases were
excluded because of technical difficulties related to the
Table 3 Cell cycle and DNA damage markers in early
Alzheimer’s disease
Cerebelar Nuclei
Case Con/AD Cyclin A pATM1981 53BP1
HCB03 AD(0.5) 0 0 0
HCB04 AD(0.5) 0 0 0
HCB07 AD(0.5) 0 0 3
HCB08 AD(0.5) 0 0 0
HCB11 AD(0.5) 5 1 0
Hippocampus
Case Con/AD Cyclin A pATM1981 53BP1
HCB03 AD(0.5) 2 4 3
HCB04 AD(0.5) 2 3 2
HCB07 AD(0.5) 1 4 3
HCB08 AD(0.5) 1 1 1
HCB11 AD(0.5) 1 4 5
Five cases of early AD from the Washington University at St. Louis ADRC were
stained for the presence of cell cycle proteins and DNA damage markers in
the cerebellar dentate nuclei and hippocampus. Each sample was scored
based on % of CDN neurons stained and the staining intensity.
Chen et al. Molecular Neurodegeneration 2010, 5:60
http://www.molecularneurodegeneration.com/content/5/1/60
Page 5 of 11
preservation of the autopsy material. These difficulties
precluded us from doing FISH analysis, even though all
samples were suitable for immunohistochemistry.
Unexpectedly, we found a very high rate of polyploidy
(extra chromosome copies indicating DNA replication)
in the neurons of the CDN in both AD and control
samples. The values ranged from 4% to 23% of the total
number of deep nuclear neurons (Figure 4). Averaged
across all probes and all cases, we observed no signifi-
cant difference (p = 0.9) in the percentage of hyperploid
dentate nuclear neurons between AD (13.5 ± 6.1%) and
controls (15.2 ± 4.4%). FISH evidence for high levels of
hyperploidy in both AD and control samples have been
documented before by other labs but these results are in
apparent conflict with our previous report on human
hippocampus material [21]. We discuss the reasons for
this discrepancy in more detail in the Discussion sec-
tion. We also scored 3 ‘disease controls’; two had been
diagnosed with frontotemporal lobe dementia-17 (16.5%
hyperploid neurons) and one with progressive supranuc-
lear palsy (PSP, 23% hyperploid neurons).
Though represented by only a single individual, the PSP
case is particularly interesting. The high rate of poly-
ploidy found in this case is consistent with the fact that
PSP patients manifest cerebellar ataxia [34]. Intriguingly,
this PSP case also had the highest percentage of CDN
stained with cyclin A, a robust presence of the PHF-1 tau
epitope, an increase in staining for the cell death marker,
cleaved caspase 6, and a clear reduction of neuronal den-
sity (Figure 5). However, this case stained negative for
DNA damage response markers 53BP1 and P-ATM.
Taken together these results suggest an important link in
this condition between true CCE and neuron loss.
Clinical-pathological correlations
The appearance of a cellular stress response - DNA
damage and cell cycle protein expression - in the cere-
bellar dentate neurons suggests that there might be
detectable deficits in cerebellar related neurological
signs. We retrospectively reviewed the neurological
symptoms reported in the subjects’ clinical records and
attempted to correlate the reported symptoms with the
Figure 3 Cyclin A expression negatively correlates with 53BP1 or P-ATM expression in cerebellar dentate nuclei. Two sections from an
AD patient were first stained with cell cycle marker Cyclin A (CycA), then stained with DNA damage markers 53BP1 or P-ATM. Staining of Cyclin
A was visualized by peroxidase substrate DAB (brown staining, red arrow). 53BP1 (left panels) or P-ATM (right panels) was visualized by Vector
VIP (purple staining, black arrow) or Vector blue (blue staining, blue arrow). Cyclin A and the DNA damage markers 53BP1 or P-ATM were
consistently found in different CDN neurons, the insets represent high magnification reproductions of the cells indicated by the arrows in the
main panel.
Figure 4 The incidence of hyperploidy is high in dentate
nucleus neurons from both AD and control samples. Figures
A-C show a representative polyploid cerebellar dentate nuclear
neuron. (A) FISH probe fluorescence (green spots) indicates three
genomic copies of the probe. The red color is due to the
autofluorescence of the neuronal lipofuscin. (B) DAPI counterstain
shows the location of the nucleus. (C) Merge of A and B. (D) Bar
graph shows the results of scoring of about 100 neurons per case
for the presence of 3-4 spots in a single dentate neuronal nucleus.
The t-test statistic indicates that there is no significant difference (p
= 0.9) between controls (15.2 ± 4.4%) and AD (13.5 ± 6.1%).
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presence or absence of cell cycle and DNA damage mar-
kers. This review was limited to any chart notations sug-
gesting motor symptoms that might be cerebellar in
origin - intention tremor, clumsiness or overt ataxia -
and unorthodox cerebellar signs such as speech/lan-
guage deficiencies and motor planning difficulties. None
of the classic cerebellar signs correlated in any signifi-
cant fashion with the DNA damage response, with cell
cycle protein levels or with polyploidy in the deep cere-
bellar neurons. There was, however, a clear correlation
between cyclin A expression and unorthodox cerebellar
signs. Moderate to high levels of cyclin A in CDN seem
to predict deficits in speech, language and motor plan-
ning, however, the reverse was not true (Table 4).
Discussion
In this study, we provide evidence that cerebellar den-
tate neurons are targets of AD pathology. As the
neurological and behavioral symptoms and neurobiolo-
gical aspects of AD are complex, a distributed pathology
that includes the cerebellum is not unexpected. We sub-
mit that our data argue for the inclusion of the cerebel-
lar dentate nucleus in the list of nervous structures that
are affected in AD.
It is intriguing to consider AD symptomatology in
light of the non-motor functions of the cerebellum.
Decreased verbal fluency is an early finding in AD, and
may be related to retrieval slowing. The participation of
the cerebellum in speech and language has been recog-
nized for some time (Schmahmann and Sherman, 1998
[3] and references therein). Functional imaging studies
show that the lateral cerebellum is engaged when a sub-
ject performs a “word generation” task such as deter-
mining an appropriate verb to use with a particular
noun [35]. Planning and problem solving difficulties
may also be related to the degradation of cerebellar
function. Whether or not the cerebellum is primarily
involved in the actual cognitive dimensions of these pro-
cesses, decreased cerebellar function places an individual
at a disadvantage when it comes to sequencing and
planning complex tasks. There is also physiological evi-
dence for anatomical connections between cerebellar
and limbic structures [1]. Schmahmann and Sherman
designate the totality of these symptoms as the “cerebel-
lar cognitive affective syndrome” [3]. Our findings sug-
gest that the full clinical syndrome of AD includes
deficits that are due in part to loss of neuronal function
in the deep cerebellar nuclei.
We are not the first to suggest cerebellar involvement
in AD [6-11,36]. However, to our knowledge, there have
been no reports that directly link the cerebellar deep
nuclei to AD. Our findings also add a new type of evi-
dence to the argument. We have shown that in AD a
portion of the cerebellar dentate neurons manifest
higher levels of markers associated with DNA damage
and cell cycle events. If the appearance of the S-phase
cyclin, cyclin A, is used as a marker there is a significant
cell cycle involvement of the neurons of the deep cere-
bellar nuclei in AD cases compared to controls. The
levels of cyclin A are significantly correlated with disease
state. Paradoxically, however the appearance of elevated
PCNA levels (a second S-phase marker of the cell cycle)
are not disease correlated. The discrepancy may be
explained by the fact that PCNA is involved in both cell
cycle progression and DNA damage repair [30].
FISH evidence for high levels of hyperploidy (extra
chromosomal material) in both AD and control samples
raises several important issues. The absence of correla-
tion between the appearance of cell cycle proteins and
evidence of DNA replication might be due to the fact
that expression of specific cell cycle proteins can be
turned on and off. Polyploidy, by contrast, is irreversible.
Figure 5 A comparison of various neuronal stress markers in
the CDN of AD, PSP (progressive supranuclear palsy) and
control. Top row: while hyperphosphorylated tau (AT8 staining) is
absent in control (column 1) and AD (column 2) samples of CDN,
its expression in PSP neurons (column 3) is quite strong. Second
row: the reverse pattern is found for the DNA damage response
(P-ATM). DNA damage is prevalent in AD but absent in PSP; control
samples are negative. Third row: cell cycle reentry (CycA
immunostaining) reveals yet a different pattern; it is absent in
controls, but present in CDN neurons of both AD and PSP. Fourth
row: the cell death marker, cleaved caspase 6 (cCasp6) appears to
reproduce the pattern seen with the cell cycle markers; clear
neuronal staining in both AD and PSP.
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If the polyploid cells do not die, or if they die slowly,
they would remain a substantial fraction of the popula-
tion, even if regulation of cell cycle protein levels
returned to normal. Perhaps more significant is the fact
that the high levels of hyperploidy we observed in the
non-demented control cases is at odds with our earlier
studies in hippocampus and basal nuclei [21]. This dis-
crepancy can be partly explained by the increased sensi-
tivity of the method used in the current study compared
to that used by us previously. Other labs have addressed
the same problem [37-40]; the common thread in all
reports is that while the absolute numbers of hyperploid
neurons in normal individuals may be uncertain, this
number is significantly increased in affected regions of
the Alzheimer’s disease brain. We also take note of
recent lineage tracing studies showing that the deep cer-
ebellar neurons are derivatives of the rhombic lip rather
than the ventricular zone of the fourth ventricle [41]. As
the rhombic lip is the source of one of the few known
tumors of the CNS that is neuronal in origin (medullo-
blastoma) it is possible that cell cycle regulation in this
lineage is unique among the neurons of the central ner-
vous system.
The expression of DNA damage-related proteins in
the deep cerebellar neurons is a robust and consistent
marker of disease in the cerebellar dentate nucleus. The
appearance of DNA damage during the course of late-
onset neurodegenerative disease has been attributed in
part to the fact that neurons exhibit high mitochondrial
respiration, which is known to lead to the production of
reactive-oxygen-species. Over time this oxidative stress
results in the accumulated damage of mitochondrial and
nuclear DNA [29]. In the current report we show that
the chromosome binding protein, 53BP1, and the acti-
vated DNA damage response kinase, P-ATM, are both
significantly elevated in AD cases with Braak stage of V
or above. The occurrence of DNA damage in AD hippo-
campus has been reported previously using the modified
histone, g-H2AX as marker [42]. In this study, however,
the response was restricted to astrocytes and discussed
as representing a part of the reactive astrocytosis. In the
current study, it is the neurons within the cerebellar
dentate nucleus that show the robust DNA damage
response. This discordance will be pursued in a future
study, especially as we have shown that the Chk2 check-
point kinase protein, a downstream substrate of ATM,
is activated in the astrocyte population of the cerebellar
dentate nuclei (in keeping with the findings of Myung
et al. [42]).
The cases we were able to study of individuals who
died at early stages of their dementia (CDR 0.5), while
few in number, are particularly informative as to the
onset of deep nuclear abnormalities in the Alzheimer’s
disease process. Of the 5 individuals we examined, only
two had evidence of either DNA damage or cell cycle
protein expression in CDN. This can be contrasted with
Table 4 Correlation of neurological symptoms with cell cycle and DNA damage markers
Case ID Age Gender Diagnoses Braak stage CCE (CycA) DDR (P-ATM) Motor status Unorthodox
cerebellar signs
Classic cerebellar signs
S/L MP Bal AT IT NYS WBS
A06-149 81 F AD REG V/VI ++ +++ abnormal yes yes yes no no no no
A08-14 81 M AD REG V/VI + +++ abnormal yes yes yes no no no no
A08-15 86 F AD REG V/VI + ++ abnormal no no no no no no no
A08-32 75 F AD REG VI + ++ normal no no no no no no no
A08-42 35 M AD REG V/VI + +++ abnormal no yes yes no no no no
A08-63 55 M AD REG VI + +++ abnormal no yes yes no no no no
A08-75 90 F AD REG V - +++ normal no no no no no no no
A08-78 76 M AD REG VI ++ +++ abnormal yes yes yes no no no no
A08-52 85 F PSP-R SEVERE +++ + abnormal yes yes yes no no no no
A08-19 52 M GI BLEED V ++ - abnormal yes yes no no no no no
A08-20 83 M ETOH/CM V + +++ normal no no no no no no no
A06-127 74 M AML/GVHD 0 - - normal no no no no no no no
A08-13 77 F CHF I/II - + abnormal no no yes no no no no
A06-106 73 M CYSTIC FIBROSIS 0 - - normal no no no no no no no
A06-69 78 M INFARCTS 0 - - abnormal yes yes yes no no no no
A06-131 85 M SEPSIS/CHF 0 - - abnormal yes no yes no no no no
Sixteen subjects that had both clinical records of neurological symptoms as well as immunohistochemistry results for cyclin A and P-ATM are presented here.
Each sample was scored based on % of CDN neurons stained and the staining intensity. “-” means no staining; “+” means very few cells stained or weakly
stained; “++” means moderate staining and “+++” means robust staining in more than half of the CDN neurons counted. None of the classic cerebellar signs
correlated with DNA damage response or cell cycle protein level. But, there was a clear correlation between high cyclin A expression in CDN and unorthodox
cerebellar signs - speech/language and motor planning. Abbreviations: S/L (speech/language), MP (motor planning), Bal (balance), AT (ataxia), IT (intention
tremor), NYS (Nystagmus) and WBS (wide base stance).
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the hippocampus data from the same individuals in this
study (Table 3) and our earlier work in the entorhinal
cortex and hippocampus [22]. In every case, hippocam-
pal neuronal cell cycle events were found to be as preva-
lent in individuals with mild cognitive impairment
(MCI) as they were in cases that had progressed to full
AD. The implication is that the involvement of the cere-
bellar dentate nucleus occurs later in the progression of
the disease. The fact that cell cycle and DNA damage
events are found in two different cases of early stage
AD also suggests that these two events are temporally
sequential or mutually exclusive. Indeed, accumulat-
ing evidence has suggested a weak response to DNA
damage is associated with the initiation of a quick
death, and this correlation may underlie aspects of the
selective neuronal vulnerability observed in aging and
neurodegenerative disease. For example, the number of
Purkinje cells is significantly reduced during aging, but
there is no parallel increase in DNA damage. By con-
trast, granule cell loss is insignificant during the aging
process, but there is a significant increase in DNA
damage markers in these cells [43,44]. In this regard it
is worth considering that P-ATM and 53BP1 immunor-
eactive neurons in cerebellar dentate nucleus might per-
sist, while cyclin A positive neurons might be destined
to die. This prediction is consistent with the clinical-
pathological data that link high cyclin A expression to
difficulty in speech/language and motor planning.
Conclusions
The results presented here reveal that the CDN neurons
are under cellular stress in AD and suggest that at least
some of the non-motor symptoms found in patients
with AD may be partly cerebellar in origin. Our findings
also emphasize the value of using direct markers of neu-
ronal distress - cell cycle events and DNA damage - as
pathological markers in AD. They augment the classical
histopathological picture achieved by staining for amy-
loid plaques and tau inclusions by providing an early
neuronal vulnerability marker. As with the appearance
of hyperphosphorylated tau, increased neuronal cell
cycle events are not disease specific [23]. However, they
unify the disease phenotype in human AD and its trans-
genic mouse models, and provide a perspective on the
human disease that adds depth and insight.
Methods
Human cases
Formalin-fixed and paraffin-embedded 10 μm consecu-
tive sections from cerebellar cortex and dentate nuclei
from 46 AD and age-matched controls were obtained
from the Alzheimer’s Disease Research Centers at Case
Western Reserve University and Washington University
School of Medicine. Some of the cases we used for the
study had been clinically diagnosed with AD and were
subsequently confirmed with standard pathological
examination. Other cases died without a clinical diagno-
sis of AD, but, neuropathological examinations were
scored as being either Braak stage V or VI. For the pur-
poses of this study these cases were defined as AD. In
addition, 5 cases of early stage AD (CDR0.5), obtained
from the Washington University Alzheimer’s Disease
Research Center, were also included in the study. The
Clinical Dementia Rating (CDR) [45] reflects cognitive
status at the neurological exam most immediately pre-
ceding death. The CDR scale ranges from 0 to 3 (0, 0.5,
1, 2, and 3). A CDR score of 0 indicates no dementia.
Antibodies
All antibodies used here are commercially available. To
detect DNA damage, we used a rabbit polyclonal 53BP1
antibody (ab36823, Abcam); a rabbit polyclonal antibody
against phosphorylated Chk2 kinase (on threonine resi-
due 68) - P-Chk2 (ab38461, Abcam) and a rabbit mono-
clonal antibody against phosphorylated ATM kinase (on
serine residue 1981) - P-ATM (ab81292, Abcam). The
specificity of these antibodies was confirmed by Western
blot and by immunofluorescent staining in neuroblas-
toma cells treated with etoposide and H2O2. Antibodies
against cyclin A (ab7956, Abcam), Cdk4 (sc-260, Santa
Cruz Biotech), and PCNA (ab18197, Abcam; sc-56,
Santa Cruz Biotech) were used to detect cell cycle
events. Cell death was evaluated using cleaved caspase 6
antibody (ab52295, Abcam). Phosphorylated tau mono-
clonal antibody (AT8) and beta amyloid, 1-16 monoclo-
nal antibody (6E10) was purchased from Thermo
Scientific and Covance. The specificity of these antibo-
dies has been established previously and confirmed by
us through the use of Western blots.
Immunohistochemistry
The human materials were formalin-fixed, paraffin-
embedded and sectioned at 10 μm sections. These were
treated as described previously [20]. All sections under-
went antigen retrieval with high temperature citrate buf-
fer for 20 min, and then soaked in 0.3% hydrogen
peroxide to remove endogenous peroxidase activity. Pri-
mary antibody was diluted in 10% goat serum with 0.5%
Tween-20. The primary antibodies used and their dilu-
tions were as follows: 53BP1, 1:1000; P-ATM, 1:250; P-
Chk2, 1:250; Cyclin A, 1:500; Cdk4, 1:200 and PCNA,
1:2000. Primary antibodies were detected using biotiny-
lated goat anti-rabbit or anti-mouse secondary antibody
(1:400), avidin-biotin complex horseradish peroxidase
and peroxidase substrates including DAB, DAB+Ni and
VIP (Vector Laboratories). Some sections were counter-
stained with hematoxylin QS. For double staining, alka-
line phosphatase linked secondary antibodies and Vector
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Blue or Vector Red were used (Vector Laboratories).
Stained sections were photographed and viewed at a
final magnification of 200 using Leica Application Suite/
Leica DM5000B. All neurons in the serpentine belt of
cerebellar dentate nuclei on each section were exam-
ined. Each case/section was given a score according to
the following criteria: 0 = no staining; 1 = very few cells
stained or weakly stained; 2 = 5-10%, moderately
stained; 3 = 10-25% moderately to strongly stained; 4 =
more than 25% strongly stained; 5 = more than 50%
strongly stained.
Fluorescent in situ hybridization (FISH)
FISH was performed as described previously [21].
Briefly, chromosome 11 probe (11q23.3-24.1) was made
from a bacterial artificial chromosome (BAC), which
encodes the human BACE1 gene. BAC DNA was
labeled by standard nick-translation protocols using
digoxygenin-labeled dUTP (Roche). Sections were
deparaffinized, pretreated with 30% Pretreatment Pow-
der (Oncor) for 11-15 min at 45°C, and digested with
0.25 mg/ml protease in 2 × SSC (Oncor) for 20-25 min
at 45°C. For each reaction, 100 ng of probe was applied
to each section and denatured with the sections at 90°C
for 12 min. The sections were then incubated at 37°C
overnight. The next day, slides were washed with 50%
fomamide/2 × SSC, 0.1 × SSC and then PBST. Primary
and secondary antibodies used to detect digoxygenin-
labeled DNA were: mouse anti-digoxygenin (Vector
Laboratories) and Alexa 647 goat anti-mouse (Invitro-
gen) both diluted 1:200 in 10% goat serum. Sections
were counterstained with DAPI (Invitrogen). An average
of 100 large cerebellar dentate nucleus neurons per sec-
tion was scored. AD and control cases were processed
under the identical conditions.
Statistics
Control cases with Braak’s stage V and higher were
grouped with AD for statistical analysis. Statistical sig-
nificance was calculated using Student’s t-test, Fisher’s
exact test and Chi-square with Yates correction. Corre-
lation (r = Multiple R) and p values for the null hypoth-
esis (no correlation) were calculated using Excel Data
Analysis Tool/Regression.
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